Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/sciences-de-la-vie/transplantation-bioengineering-and-regeneration-of-the-endocrine-pancreas-volume-2/descriptif_4183285
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4183285

Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas Volume 2

Langue : Anglais

Coordonnateurs : Orlando Giuseppe, Piemonti Lorenzo, Ricordi Camillo, Stratta Robert J., Gruessner Rainer W.G.

Couverture de l’ouvrage Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas

Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas, Volume 2, sets a new standard in transplant and regenerative medicine. The book details the state-of-the-art in modern islet auto-transplantation, also discussing current progress in regenerative medicine research in diabetes medicine. Regenerative medicine is changing the premise of solid organ transplantation, hence this volume catalogs technologies being developed and methods being implemented. Bioengineering and regenerating beta cells, clinical pancreas and islet transplantation, tissue engineering, biomaterial sciences, stem cell biology and developmental biology are all addressed and applied directly to diabetes medicine.

PART A.  ISLET ALLO-TRANSPLANTATION Section I. Chronic Pancreatitis Section II. Islet Auto-Transplantation for Chronic Pancreatitis Section III. Outcomes

PART B. BIOENGINEERING AND REGENERATION OF THE ENDOCRINE PANCREAS Section I. Pancreas Development and Regeneration Section II. Scaffolds for Endocrine Pancreas Bioengineering Section III. Islet Encapsulation Section IV. Stem Cells to Generate Insulin Producing Cells Section V. Animal-based Platforms for Pancreas Bioengineering Section VI. Tissue Engineering Technologies Applied to Beta Cell Replacement Section VII. Regulation and Funding Section VIII. Conclusive Remarks

Transplant, regenerative medicine and diabetes investigators, basic scientists, biomedical engineers.

Giuseppe Orlando, MD, PhD, Marie Curie Fellow, is an Associate Professor and a kidney and pancreas transplant surgeon scientist at the Wake Forest University School of Medicine, in Winston Salem, USA. His research aims at developing platforms for the bioengineering and regeneration of transplantable organs, and at developing therapies to enhance the innate ability of the human body to repair itself after damage. His literature output aims at bridging organ transplantation to regenerative medicine.
At the San Raffaele Scientific Institute (Milan, Italy) Lorenzo Piemonti serves as Director of Diabetes Research Institute and Director of Human Islet Transplantation Program. He also serves as Head of the Beta Cell Biology Unit (Diabetes Research Institute), Director of Human Islet Processing Facility, and coordinator of European Consortium for Islet Transplantation that has been providing Human beta Cell Products for research across state barriers in Europe since 2000. He also serves as Professor in Endocrinology at University “Vita Salute San Raffaele” of Milan and as Honorary Visiting Professor at Vrije Universiteit of Brussel. His area of expertise is mainly focused on diabetes and pancreatology. In particular he has large experience about diabetes and pancreatic cancer. He had in the past studied the role of innate immunity in islet cell biology (especially in the human model of islet transplantation in type 1 diabetes recipient) and in pancreatic cancer biology (especially the role of chemokines and chemokine receptor system in inducing leukocytes infiltration). More recently, his research interests includes beta cell replacement, immune tolerance induction strategies, dendritic cell biology, stem cells. He currently serves as section Editor of Cell Transplantation-the Regenerative Medicine Journal and of Current Diabetes Reports, as editorial board of Acta Dibetologia, as Councilor of the International Pancreas and Islet Transplantation Association (IPITA) of T
  • Provides comprehensive and cutting-edge knowledge of whole pancreas and islet transplantation
  • Addresses imaging, treatment, scaffold technology, the use of stem cells to generate insulin, 3D printing, and more
  • Offers an update on the progress of regenerative medicine research aimed at beta cell replacement for the treatment of diabetes

Date de parution :

Ouvrage de 560 p.

21.4x27.6 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

241,29 €

Ajouter au panier

Thème de Transplantation, Bioengineering, and Regeneration of the... :